A Multicenter, Retrospective Study Analysis: Evaluating the Efficacy and Safety of Pembrolizumab in the First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined